News & Events

GreenMark Biomedical Secures Follow-On Regenerative Medicine Grant Funding

ANN ARBOR, MI, UNITED STATES, August 25, 2026 – GreenMark Biomedical Inc. announces its project entitled “Targeted Remineralization Treatment Using Mineral Loaded Starch Nanoparticles” has been selected for additional funding by the Translational Resource Center. GreenMark will receive up to $297,615 in additional funding to advance new forms of its innovative regenerative products for noninvasive mineralization of early-stage […]

Read More

GreenMark Biomedical Secures Third NIH Grant in 2025

ANN ARBOR, MI, UNITED STATES, November 11, 2025 – GreenMark awarded NIH grant to advance its innovative regenerative technology for noninvasive mineralization of early-stage dental decay. GreenMark Biomedical Inc., a company developing innovative solutions for oral health, earlier this year was awarded funding via the Translational Resource Center (TRC) regenerative medicine program, as well as […]

Read More

Expanding GreenMark Biomedical Regenerative Dental Treatment Product Line

ANN ARBOR, MI, UNITED STATES, July 16, 2025 — GreenMark Biomedical Inc. announces its project entitled “Targeted Remineralization Treatment Using Mineral Loaded Starch Nanoparticles” has been selected for additional funding by the Translational Resource Center (TRC)’s Interdisciplinary Translational Project (ITP) program. GreenMark will receive up to $162,000 in additional funding to advance new forms of its innovative […]

Read More

GreenMark Announces NIH Funding for AI-Enabled Early Caries Detection

ANN ARBOR, MI, UNITED STATES, April 3, 2025 – GreenMark Biomedical Inc., a pioneer in leveraging biomimetic technology for dental health innovations, announces that it has received a Phase I Small Business Innovation Research (SBIR) grant in the amount of US $ 294,632 from the National Institutes of Health (NIH).

Read More

GreenMark Announces Distribution Partnership with Great Oral Health

ANN ARBOR, MI, UNITED STATES, January 22, 2025 – Great Oral Health adopts CrystLCare™ Biorestorative, Fluoride-Free dental strips into its product line to help combat dental sensitivity and strengthen enamel.

Read More

GreenMark Secures FDA Clearance for CrystLCare™ PRO Biorestorative

ANN ARBOR, MI, UNITED STATES, January 7, 2025 – GreenMark Biomedical Inc., a pioneer in leveraging biomimetic technology for dental health innovations, today announced that the company has secured regulatory clearance from the U.S. Food and Drug Administration (FDA) to market its CrystLCare™ PRO Biorestorative, Fluoride-Plus product as a 510(k) Class II Medical Device.

Read More

GreenMark Biomedical Publishes Results on Remineralization of Tooth Decay with Mineral-loaded Starch Particles

“The study reveals compelling in vitro data supporting GreenMark’s CrystLCare™ Biorestorative technology, which offers a non-invasive solution for addressing early-stage dental caries. This breakthrough research resulted from an NIH-funded collaboration of investigators at top dental schools together with the GreenMark team.”

Read More